We drive Life Science success with targeted project leadership and unparalleled expertise in delivering efficient, high-impact solutions.
NPG’s Project Management team serves the unique needs of both medical device and pharmaceutical clients. While key strengths like industry focus, certified expertise, and clear communication are vital across sectors, medical device clients benefit from proactive risk management, while pharmaceutical clients leverage our end-to-end services and adaptability. Together, these capabilities ensure NPG delivers impactful results for every life sciences project.
NPG offers tailored solutions to meet specific client needs. Our core services enhance efficiency, foster alignment, and support strategic goals in pharmaceutical and medical devices. This includes project management services such as:
» Design Control & Risk Management
» Supply Chain Optimization
» Clinical Trial Management
» Quality Management System (QMS) Implementation
» Technology Transfers
» Mergers, Acquisitions, and Divestitures
Our team expertly manages design control and embeds comprehensive risk management practices throughout the product lifecycle. By aligning processes with FDA, EU MDR, and other critical industry standards, we ensure every product stage meets regulatory compliance, maintaining quality, safety,and reliability.
NPG boosts supply chain efficiency by streamlining supplier qualification, conducting thorough quality control, and aligning with regulatory standards. Our approach ensures dependable production and delivery of compliant medical device components, supporting smooth operations and minimizing risks across the supply chain.
Our project managers oversee medical device clinical trials from protocol design to study closeout. We prioritize data integrity and strict adherence to regulatory standards, ensuring trials run efficiently and meet compliance requirements, for successful outcomes and reliable results in every phase.
We design, implement, and sustain QMS frameworks tailored to the rigorous standards of medical device regulations. Our approach ensures compliance with global requirements, fosters a strong culture of quality, and promotes continuous improvement across all operations to drive product excellence and regulatory alignment.
We oversee seamless technology transfers across R&D, clinical, and commercial sites,ensuring consistency and operational efficiency. Our process maintains quality control during transitions between production locations or CMOs, minimizing risks and supporting uninterrupted progress across all stages of production.
NPG's M&A programs execute the operational, regulatory and technology changes required with mergers, acquisitions and divestiture initiatives. With subprogram expertise in technical transfer, regulatory strategy and submissions and operational transformation, NPG’s program management teams provide the fully outsourced solutions for M&A execution.
Partnering with NPG transformed our project timelines. Their project management team’s precise and expert guidance allowed us to overcome roadblocks quickly and stay on schedule. We now deliver projects faster and with more consistency than ever before.
— Medical Device Client
Project Manager
NPG’s experts are more than project managers; we’re dedicated partners committed to elevating your initiatives with precision, efficiency, and strategic insight. NPG guides companies through critical checkpoints,proactively preventing roadblocks. Learn how our expertise helps clients streamline workflows, overcome challenges, and achieve exceptional project outcomes in our project management case studies.
Mark is a seasoned leader in the pharmaceutical and medical device industries, currently serving as the President of Network Partners Group. His career is marked by strategic program management and quality compliance expertise, with significant roles at Primecore Program Management, Treximo, and Pfizer. Mark has a robust background in quality compliance, having overseen operational quality at Pfizer and managed quality assurance at Mallinckrodt Pharmaceuticals. His educational background includes an MBA in Finance and Biotechnology from North Carolina State University and a Bachelor’s degree in Chemical Engineering from Virginia Tech.
"*" indicates required fields
